OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance
Jiao Li, Dan Sun, Wenchen Pu, et al.
Trends in cancer (2020) Vol. 6, Iss. 4, pp. 319-336
Closed Access | Times Cited: 549
Jiao Li, Dan Sun, Wenchen Pu, et al.
Trends in cancer (2020) Vol. 6, Iss. 4, pp. 319-336
Closed Access | Times Cited: 549
Showing 1-25 of 549 citing articles:
Circular RNA: metabolism, functions and interactions with proteins
Wei‐Yi Zhou, Zerong Cai, Jia Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 874
Wei‐Yi Zhou, Zerong Cai, Jia Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 874
Applications of multi‐omics analysis in human diseases
Chongyang Chen, Jing Wang, Donghui Pan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 172
Chongyang Chen, Jing Wang, Donghui Pan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 172
Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC
Shiwei Chen, Shu‐Qiang Zhu, Xu Pei, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 170
Shiwei Chen, Shu‐Qiang Zhu, Xu Pei, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 170
Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit
Cunying Ma, Xiaoying Wang, Fenghua Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 149
Cunying Ma, Xiaoying Wang, Fenghua Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 149
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer
Jiaxin Chen, Yizheng Wu, Xin Luo, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7507-7526
Open Access | Times Cited: 141
Jiaxin Chen, Yizheng Wu, Xin Luo, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7507-7526
Open Access | Times Cited: 141
Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer
Fei Long, Zhi Lin, Liang Li, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 140
Fei Long, Zhi Lin, Liang Li, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 140
Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer
Hao Shen, Boqiang Liu, Junjie Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 104
Hao Shen, Boqiang Liu, Junjie Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 104
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
Juan Jin, Yuhao Xie, Jin-Shi Zhang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100929-100929
Open Access | Times Cited: 84
Juan Jin, Yuhao Xie, Jin-Shi Zhang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100929-100929
Open Access | Times Cited: 84
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
Di Huang, Xiao‐Feng Zhu, Shuying Ye, et al.
Nature (2023) Vol. 625, Iss. 7995, pp. 593-602
Closed Access | Times Cited: 84
Di Huang, Xiao‐Feng Zhu, Shuying Ye, et al.
Nature (2023) Vol. 625, Iss. 7995, pp. 593-602
Closed Access | Times Cited: 84
Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
Hongbo Wang, Qinghai Meng, Jinjun Qian, et al.
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108123-108123
Closed Access | Times Cited: 81
Hongbo Wang, Qinghai Meng, Jinjun Qian, et al.
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108123-108123
Closed Access | Times Cited: 81
Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
Roy S, Mitsuro Kanda, Sachiyo Nomura, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 78
Roy S, Mitsuro Kanda, Sachiyo Nomura, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 78
Exosomes rewire the cartilage microenvironment in osteoarthritis: from intercellular communication to therapeutic strategies
Yuangang Wu, Jiao Li, Yi Zeng, et al.
International Journal of Oral Science (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 72
Yuangang Wu, Jiao Li, Yi Zeng, et al.
International Journal of Oral Science (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 72
CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
Yuying Zhang, Jingyan Luo, Weikang Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 67
Yuying Zhang, Jingyan Luo, Weikang Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 67
Circular RNAs in breast cancer diagnosis, treatment and prognosis
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
X. Huang, Cailu Song, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 57
HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway
Jiancheng Lv, Kai Li, Hao Yu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 55
Jiancheng Lv, Kai Li, Hao Yu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 55
Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy
Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16484-16484
Open Access | Times Cited: 49
Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16484-16484
Open Access | Times Cited: 49
CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS
Yi Jia, Lei Wang, Guo‐sheng Hu, et al.
The EMBO Journal (2023) Vol. 42, Iss. 10
Open Access | Times Cited: 44
Yi Jia, Lei Wang, Guo‐sheng Hu, et al.
The EMBO Journal (2023) Vol. 42, Iss. 10
Open Access | Times Cited: 44
CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis
Zaosong Zheng, Xiangbo Zeng, Yuanchao Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Zaosong Zheng, Xiangbo Zeng, Yuanchao Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs
Xiaojun Shi, Shiyu Pang, Jiawei Zhou, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Xiaojun Shi, Shiyu Pang, Jiawei Zhou, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study
Zerong Cai, Yongqiang Zheng, Yan Hu, et al.
Gut (2025), pp. gutjnl-333522
Closed Access | Times Cited: 4
Zerong Cai, Yongqiang Zheng, Yan Hu, et al.
Gut (2025), pp. gutjnl-333522
Closed Access | Times Cited: 4
Noncoding RNA (ncRNA)-mediated regulation of TLRs: critical regulator of inflammation in tumor microenvironment
Tawfeeq Alghazali, Abdulrahman T. Ahmed, Uday Abdul‐Reda Hussein, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 2
Tawfeeq Alghazali, Abdulrahman T. Ahmed, Uday Abdul‐Reda Hussein, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 2
CircRNAs in lung cancer - Biogenesis, function and clinical implication
Chengdi Wang, Shuangyan Tan, Jingwei Li, et al.
Cancer Letters (2020) Vol. 492, pp. 106-115
Open Access | Times Cited: 122
Chengdi Wang, Shuangyan Tan, Jingwei Li, et al.
Cancer Letters (2020) Vol. 492, pp. 106-115
Open Access | Times Cited: 122
